DENVER, Aug. 09, 2021 (GLOBE NEWSWIRE) —
NewAge, Inc. (Nasdaq: NBEV),
the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced record financial results for the second quarter of 2021 with a net revenue of $124 million, net income of $17.4 million, adjusted EBITDA
1
of $1.7 million, and basic earnings per share of $0.11.
For the three months ending June 30, 2021, net revenue was $124 million, an increase of $61 million or 98%. Gross profit for the quarter was $84 million, an increase of $46 million or 120%, resulting in a gross margin of 67.6%, compared to a 60.8% in the prior-year period, an increase of 6.8 percentage points. Net income was $17.4 million, an increase of $26.9 million compared ot a net loss of ($9.6) million in the prior-year period. Adjusted EBITDA was $1.7 million, an increase of $7.2 million compared to a loss of ($5.5) million in the prior-year period. Basic earnings per share was a positive $0.11, an increase of $0.21 compared to a loss of ($0.10) in the prior-year period.
Brent Willis, Chief Executive Officer of NewAge, commented, “The second quarter saw accelerated top and bottom-line results and continued income statement improvement. In the quarter, we completed the Aliven acquisition, had a very successful annual meeting, further integrated ARIIX capturing additional cost and revenue synergies, and continued expansion of our social selling initiatives worldwide. We strengthened our team and positioned NewAge for even further transformative performance as our strategy unfolds.”
“This is our third consecutive quarter of positive adjusted EBITDA,” commented Kevin Manion, NewAge’s new Chief Financial Officer. “Financially, our focus is on developing, utilizing and driving consistent company-wide metrics to improve EBITDA margins through operational improvements and reducing SG&A costs, specifically from consolidating the recent acquisitions. With these activities, we are confident in continued growth throughout 2021 and thereafter. I see NewAge as extremely well positioned to deliver superior organic growth and transformative, accretive external growth. I have spent most of my career in the consumer goods industry and see the NewAge Social Selling Network and our D2C route-to-market as the new winning industry model that will deliver outsized returns for shareholders.”
Second Quarter 2021 Financial Results
Net revenue was $124 million for the three months ending June 30, 2021, versus $63 million for the second quarter of the prior year, an increase of 98%. The growth in net revenue was driven by the acquisitions of ARIIX and Aliven. Leading the growth on a proforma basis was the combined European business that increased 24% and the United States business that increased 15%. These were offset by China, Japan and the impact of COVID-19 in a number of markets around the world.
Gross margin for the second quarter of 2021 was $84 million or 67.6% of net revenue compared with $38 million or 60.8% of net revenue for the prior-year period, a 120% increase of $46 million and an increase of 6.8 gross margin percentage points. The gross margin percentage increase was driven by higher net revenue from the Direct/Social Selling Division and the disposition of the retail brands’ business completed in September 2020.
Net operating loss was ($9.6) million for the second quarter of 2021 compared to a loss of ($8.8) million for the prior-year period. Net income was $17.4 million, correlating to a positive basic EPS of $0.11 per share, an increase of 21 cents from the prior-year period. Adjusted EBITDA was $1.7 million, compared with ($5.5) million for the prior-year period, an improvement of $7.2 million.
The company ended the quarter with a strong balance sheet, with cash and cash equivalents of $92 million and debt of $31.5 million, exclusive of operating lease liabilities. Subsequent to the quarter-end, $9.7 million of debt was forgiven.
“Our second-quarter results demonstrated commendable progress converging our companies and capturing both revenue and cost synergies. Carrying this momentum forward, we expect continued strong results from operations throughout the year as we build out additional platforms and programs for our global sales force. We believe we are stronger and better positioned than we have ever been, with differentiated health and wellness brands and an on-trend D2C business system, with an expanding e-commerce Subscriber base and an increasing and strengthening team of exclusive Brand Partner influencers,” concluded Mr. Willis.
Conference Call
The company will host a live conference call and webcast today at 5:00 p.m. Eastern Time. Conference call details are provided below. Interested investors can dial into the conference call to hear the details of management’s updates and participate in a question and answer session.
Date:
Monday, August 9, 2021
Time:
5:00 p.m. ET
Toll-free dial-in number:
1-855-327-6838
International dial-in number:
1-604-235-2082
Conference ID:
10016023
The conference call will also be broadcast live and available for replay
here
and via the Investors section of the company’s website at
newage.com
. The webcast replay will be available for approximately 45 days following the call.
Please dial into the conference call 15 minutes prior to the start time due to increased demand for conference calls. You will be asked to register your name and organization.
A replay of the conference call will be available after 8:00 p.m. Eastern Time on the same day through Monday, August 16, 2021, 11:59 p.m.
Toll-free replay number:
1-844-512-2921
International replay number:
1-412-317-6671
Replay ID:
10016023
About NewAge, Inc.
NewAge is a purpose-driven firm dedicated to inspiring the planet to Live Healthy™. Colorado-based NewAge commercializes a portfolio of organic and healthy products worldwide through primarily a direct-to-consumer (D2C) route to market distribution system across more than 75 countries. The company competes in three major category platforms: Health and Wellness, Inner and Outer Beauty and Nutritional Performance and Weight Management — leading a network of more than 400,000 exclusive independent Brand Partners, empowered with the leading social selling tools and technology around the world.
The company operates the websites
NewAge.com
,
MaVie.com
and
Zennoa.com
.
Safe Harbor Disclosure
This press release contains forward-looking statements that are made under the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management’s expectations regarding future results of operations, economic performance, and financial condition, including statements related to operating margins, the acquisitions and integrations of ARIIX and Aliven and cost synergies and operational efficiencies related thereto, the acquisition of additional businesses, the impact of the coronavirus (“COVID-19”) pandemic, and plans for company growth. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. NewAge competes in a rapidly growing and transforming industry, and risk factors, including those disclosed in the company’s filings with the Securities and Exchange Commission, might affect the company’s operations. Unless required by applicable law, the company undertakes no obligation to update or revise any forward-looking statements.
For investor inquiries about NewAge please contact:
NewAge Investor Relations:
Mindy Eardley
Director, Public and Investor Relations
Tel: 1-801-573-4818
[email protected]
–
|
NewAge, Inc. |
|||||||
|
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
(In thousands, except per share amounts) |
|||||||
|
|
|
|
|
||||
|
June 30, |
December 31, |
||||||
|
ASSETS |
2021 |
2020 |
|||||
|
|
|||||||
|
Current assets: |
|||||||
| Cash and cash equivalents | $ | 80,922 | $ | 43,711 | |||
| Trade accounts receivable, net of allowance of $590 and $582, respectively | 10,470 | 12,341 | |||||
| Inventories | 44,219 | 48,051 | |||||
| Assets held for sale | 7,088 | – | |||||
| Current portion of restricted cash | 5,568 | 10,000 | |||||
| Prepaid expenses and other | 13,086 | 13,032 | |||||
| Total current assets | 161,353 | 127,135 | |||||
|
Long-term assets: |
|||||||
| Identifiable intangible assets, net of accumulated amortization | 164,093 | 169,611 | |||||
| Goodwill | 55,281 | 54,993 | |||||
| Right-of-use lease assets | 29,741 | 38,764 | |||||
| Property and equipment, net of accumulated depreciation | 23,771 | 28,076 | |||||
| Restricted cash, net of current portion | 5,969 | 11,524 | |||||
| Deferred income taxes | 7,476 | 7,782 | |||||
| Deposits and other | 4,771 | 5,297 | |||||
| Total assets | $ | 452,455 | $ | 443,182 | |||
|
LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ EQUITY |
|||||||
|
Current liabilities: |
|||||||
| Accounts payable | $ | 17,111 | $ | 22,774 | |||
| Accrued liabilities | 65,009 | 70,007 | |||||
| Operating lease liability related to right-of-use assets held for sale | 4,707 | – | |||||
| Current portion of business combination liabilities | 1,140 | 11,750 | |||||
| Current maturities of long-term debt | 19,440 | 18,016 | |||||
| Total current liabilities | 107,407 | 122,547 | |||||
|
Long-term liabilities: |
|||||||
| Business combination liabilities, net of current portion | 49,013 | 95,826 | |||||
| Long-term debt, net of current maturities | 12,063 | 16,181 | |||||
| Operating lease liabilities, net of current portion: | |||||||
| Lease liability | 26,745 | 34,788 | |||||
| Deferred lease financing obligation | 15,543 | 15,882 | |||||
| Warrant derivative liability | 5,695 | – | |||||
| Deferred income taxes | 5,091 | 5,391 | |||||
| Other | 8,295 | 8,313 | |||||
| Total liabilities | 229,852 | 298,928 | |||||
|
Redeemable Common Stock, 800 shares as of December 31, 2020 |
– | 2,101 | |||||
|
Stockholders’ equity: |
|||||||
| Preferred stock, $0.001 par value per share. Authorized 1,000 shares; no shares issued | – | – | |||||
| Common Stock, $0.001 par value per share. Authorized 400,000 and 200,000 shares as of June 30, 2021 and December 31, 2020, respectively; issued and outstanding 136,606 and 99,146 shares as of June 30, 2021 and December 31, 2020, respectively | 137 | 99 | |||||
| Additional paid-in capital | 340,937 | 236,732 | |||||
| Obligation to issue 14,551 and 19,704 shares of Common Stock as of June 30, 2021 and December 31, 2020, respectively | 30,263 | 54,186 | |||||
| Note receivable for stock subscription | – | (1,250 | ) | ||||
| Accumulated other comprehensive income | 3,478 | 4,201 | |||||
| Accumulated deficit | (152,212 | ) | (151,815 | ) | |||
| Total stockholders’ equity | 222,603 | 142,153 | |||||
| Total liabilities, redeemable Common Stock, and stockholders’ equity | $ | 452,455 | $ | 443,182 | |||
|
NewAge, Inc. |
|||||||||||||||
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
|
(In thousands, except per share amounts) |
|||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||||||
|
June 30, |
June 30, |
||||||||||||||
|
|
2021 |
2020 |
2021 |
2020 |
|||||||||||
|
|
|||||||||||||||
| Net revenue | $ | 124,040 | $ | 62,637 | $ | 249,558 | $ | 126,330 | |||||||
| Cost of goods sold | 40,241 | 24,559 | 78,358 | 46,728 | |||||||||||
| Gross profit | 83,799 | 38,078 | 171,200 | 79,602 | |||||||||||
| Operating expenses: | |||||||||||||||
| Commissions | 43,320 | 18,405 | 90,717 | 37,920 | |||||||||||
| Selling, general and administrative | 41,042 | 26,277 | 79,901 | 56,885 | |||||||||||
| Depreciation and amortization expense | 4,723 | 1,761 | 9,398 | 3,542 | |||||||||||
| Loss on disposal of Divested Business | 4,339 | – | 4,339 | – | |||||||||||
| Impairment of right-of-use assets | – | 400 | – | 400 | |||||||||||
| Total operating expenses | 93,424 | 46,843 | 184,355 | 98,747 | |||||||||||
| Operating loss | (9,625 | ) | (8,765 | ) | (13,155 | ) | (19,145 | ) | |||||||
| Non-operating income (expense): | |||||||||||||||
| Interest expense | (3,040 | ) | (600 | ) | (6,163 | ) | (1,172 | ) | |||||||
| Gain (loss) from change in fair value of derivatives | 30,829 | 20 | 21,216 | (306 | ) | ||||||||||
| Interest and other income (expense), net | (53 | ) | 342 | (405 | ) | 725 | |||||||||
| Income (loss) before income taxes | 18,111 | (9,003 | ) | 1,493 | (19,898 | ) | |||||||||
| Income tax expense | (740 | ) | (551 | ) | (1,890 | ) | (1,274 | ) | |||||||
|
Net income (loss) |
$ | 17,371 | $ | (9,554 | ) | $ | (397 | ) | $ | (21,172 | ) | ||||
| Net income (loss) per share of Common Stock: | |||||||||||||||
| Basic | $ | 0.11 | $ | (0.10 | ) | $ | (0.00 | ) | $ | (0.24 | ) | ||||
| Diluted | $ | (0.04 | ) | $ | (0.10 | ) | $ | (0.08 | ) | $ | (0.24 | ) | |||
| Weighted average number of shares of Common Stock outstanding: | |||||||||||||||
| Basic | 143,636 | 93,003 | 135,534 | 89,187 | |||||||||||
| Diluted | 170,609 | 93,003 | 166,323 | 89,187 | |||||||||||
|
NewAge, Inc. |
|||||||
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
SIX MONTHS ENDED JUNE 30, 2021 AND 2020 |
|||||||
|
(In thousands) |
|||||||
|
2021 |
2020 |
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|||||||
| Net loss | $ | (397 | ) | $ | (21,172 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Loss (gain) from change in fair value of derivatives, net | (21,216 | ) | 306 | ||||
| Depreciation and amortization | 9,596 | 3,752 | |||||
| Non-cash lease expense | 6,244 | 2,792 | |||||
| Loss on disposal of Divested Business | – | – | |||||
| Accretion of debt discount | 4,372 | 302 | |||||
| Stock-based compensation expense | 4,149 | 2,449 | |||||
| Allowance for uncollectible note receivable from Divested Business | 2,701 | – | |||||
| Impairment of right-of-use assets | – | 400 | |||||
| Expense for make-whole premium and other | – | – | |||||
| Deferred income tax benefit | (149 | ) | (173 | ) | |||
| Loss from sale of property and equipment | 60 | 66 | |||||
| Other | 118 | 73 | |||||
| Changes in operating assets and liabilities, net of effects of business combination: | |||||||
| Accounts receivable | (37 | ) | (2,276 | ) | |||
| Inventories | 4,681 | 2,819 | |||||
| Prepaid expenses, deposits and other | 1,640 | 517 | |||||
| Accounts payable | (5,840 | ) | (551 | ) | |||
| Other accrued liabilities | (11,482 | ) | (12,900 | ) | |||
| Net cash used in operating activities | (5,560 | ) | (23,596 | ) | |||
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|||||||
| Cash payments for Ariix business combination | (10,000 | ) | – | ||||
| Proceeds from sale of equipment | – | 159 | |||||
| Capital expenditures for property and equipment | (765 | ) | (1,980 | ) | |||
| Net cash used in investing activities | (10,765 | ) | (1,821 | ) | |||
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|||||||
| Proceeds from private placement of Units, net of placement fee: | |||||||
| Fair value of warrants to purchase 7,318 shares of Common Stock | 14,128 | – | |||||
| Residual fair value of 14,636 shares of Common Stock | 39,673 | – | |||||
| Proceeds from borrowings | – | 6,868 | |||||
| Principal payments on borrowings | (6,000 | ) | (10,450 | ) | |||
| Debt issuance costs paid | (21 | ) | (85 | ) | |||
| Proceeds from issuance of common stock | – | 25,122 | |||||
| Payments for deferred offering costs | (24 | ) | (94 | ) | |||
| Proceeds from exercise of stock options | 528 | 4 | |||||
| Principal payments on business combination obligations | (4,496 | ) | (298 | ) | |||
| Payments under deferred lease financing obligation | (329 | ) | (319 | ) | |||
| Net cash provided by financing activities | 43,459 | 20,748 | |||||
| Effect of foreign currency translation changes | 90 | (857 | ) | ||||
| Net change in cash, cash equivalents and restricted cash | 27,224 | (5,526 | ) | ||||
| Cash, cash equivalents and restricted cash at beginning of period | 65,235 | 64,571 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 92,459 | $ | 59,045 | |||
|
Three Months Ended |
Six Months Ended |
||||||||||||||
|
June 30, |
June 30, |
||||||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||||||
|
|
|||||||||||||||
| Net income (loss) | $ | 17,371 | $ | (9,554 | ) | $ | (397 | ) | $ | (21,172 | ) | ||||
| EBITDA Non-GAAP adjustments: | |||||||||||||||
| Interest expense | 3,040 | 600 | 6,163 | 1,172 | |||||||||||
| Income tax expense | 740 | 551 | 1,890 | 1,274 | |||||||||||
| Depreciation and amortization expense | 4,822 | 1,873 | 9,596 | 3,752 | |||||||||||
|
EBITDA |
25,973 | (6,530 | ) | 17,252 | (14,974 | ) | |||||||||
| Adjusted EBITDA Non-GAAP adjustments: | |||||||||||||||
| Stock-based compensation expense | 2,187 | 1,092 | 4,149 | 2,449 | |||||||||||
| Loss on disposal of Divested Business | 4,339 | – | 4,339 | – | |||||||||||
| Loss (gain) from change in fair value of derivatives | (30,829 | ) | (20 | ) | (21,216 | ) | 306 | ||||||||
|
Adjusted EBITDA |
$ | 1,670 | $ | (5,458 | ) | $ | 4,524 | $ | (12,219 | ) | |||||
Non-GAAP Financial Measures
The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.
_________________________________
1
EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below.
